ClinicalTrials.gg
CompletedNCT05712915Updated Feb 6, 2023

Extension of Rapid Response Team Operation Time and Cardiopulmonary Resuscitation Incidence

An observational study in Cardiopulmonary Arrest, sponsored by Dong-A University Hospital. Completed at 1 site in Korea, Republic of. Open to participants aged 19 Years and older. Per ClinicalTrials.gov, last updated 2023-02-06.

Sponsored by Dong-A University Hospital · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
142,088
Ages
19 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 44 studies in Heart Arrest with a site in Korea, Republic of — 8 open to participants now, 10 under way, none of them phase 3. Heart Arrest · Korea, Republic of.

Enrollment
2nd of 22
142,088 · median 195
Started
2019
the only one that year
Observational
22 of 44
5 open now
Registered
33rd of 44
by date

Among the 44 studies in Heart Arrest with a site in Korea, Republic of, this one is the 2nd largest by enrollment of the 22 observational ones that give a count, is the only one that started in 2019, is one of 22 observational ones, and was the 33rd registered.

Heart Arrest

927 studies on the registry are indexed under Heart Arrest; 227 are open to participants now.

Browse Heart Arrest studies →

Open to participants now

8 of the 44 studies in Heart Arrest with a site in Korea, Republic of are open now. Recruiting first, the newest first:

3 more — sign in →

All 8 open studies →

A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →

Who these studies take

Of the 157 Heart Arrest studies recruiting now, 109 (69%) set no upper age limit and 28 (18%) stop at 75 or younger; 30 take children under 18; 18 take healthy volunteers.

This study: 19 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 44 studies in Heart Arrest with a site in Korea, Republic of, or all of them as a file.
02

Study summary

Although early rapid response team was reported as a full-time operating system, similar efficacy of part-time rapid response team has been recently reported. We sought to investigate the association between the duration of rapid response team operation time and the incidence of general ward cardiopulmonary resuscitation.

Read the detailed description

Rapid response team (RRT) was introduced to reduce the preventable cardiac arrest in general wards and it has been spread worldwide. RRTs usually consist of dedicated intensivists in RRT and nurse specialists in critical care.

Although RRT implementation could useful, it is not suitable for all hospital circumstances because it is required high cost and plenty of experience in critical care settings. For this reason, to minimize the RRT operating cost, the part-time RRT operation was reported. Recently similar efficacy in part-time operation RRT was reported. However, it is difficult to compare full-time and part-time RRT and no study has been reported the efficacy according to the intensity of RRT operation time.

Authors invested the incidence of general ward cardiopulmonary resuscitation according to the RRT operation time; from the initial implementation to the full-time RRT operation after stepwise extension.

03

Conditions studied

  • Cardiopulmonary Arrest

Browse trials for

Keywords

  • cardiopulmonary arrest
  • rapid response team
  • operation time
04

Who can participate

Ages eligible
19 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients admitted to study hospital from April 1, 2014, to December 31, 2020

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients admitted to study hospital from April 1, 2014, to December 31, 2020

Exclusion criteria

Exclusion Criteria:

  1. Patients who developed CPR in elsewhere not GW (ICU, emergency department, operation room, outpatient clinics, cardiac catheterization laboratory)
  2. younger than 18 years
  3. Patients admitted via the emergency department
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
142,088 participants (actual)
Patient registry
No

Interventions

  • OtherRRT operation

    A retrospective observational study was conducted at a 990-bed tertiary care referral teaching hospital from April 2014 to December 2020. The RRT implemented in April 2017 as a part-time RRT operating 8 hours on weekdays. In March 2018, operation time was extended to 15 hours on weekdays and finally, extended to 24 hours a day, 7 days a week in February 2019. Impact of RRT operation on CPR incidence was retrospective analyzed without any prospective intervention.

06

What researchers measure

Primary outcomes

  1. General ward CPR incidence during period without RRT (rapid response team)

    Time frame: at the end of period of no RRT operation. (31th March, 2017)

  2. General ward CPR incidence during period of part time RRT

    Time frame: at the end of part time RRT period (28th February, 2018)

  3. General ward CPR incidence during period of extended part time RRT

    Time frame: at the end of extended part time RRT period (31st January, 2019)

  4. General ward CPR incidence during period of full time RRT

    Time frame: at the end of full time RRT period (31th December, 2020)

07

Study locations

1 site
  • DongA university hospital
    Busan, Seo-gu 49201, Korea, Republic of
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2019 to primary completion in Dec 2020, 23 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 18, 2023
First posted
Feb 6, 2023
StartActual
Jan 1, 2019
Primary completionActual
Dec 31, 2020
CompletionActual
Dec 31, 2021
Last update
Feb 6, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05712915
Lead sponsor
Dong-A University Hospital
Responsible party
Dong Hyun Lee (professor, Dong-A University Hospital) — Principal investigator
First posted
Feb 6, 2023
Start date
Jan 1, 2019
Primary completion
Dec 31, 2020
Completion
Dec 31, 2021
Last update
Feb 6, 2023

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion